Last edition
News about "Center for Drug Evaluation and Research (CDER)"
FDA Lifts Partial Clinical Hold on Vanda's Tradipitant for Motion Sickness
The lift allows Vanda to extend clinical studies of tradipitant in motion sickness. Meanwhile, the review of the fully completed New Drug Application for tradipitant for the prevention of vomiting induced by motion remains on track.
Center For Drug Evaluation And Research (CDER) | 05/12/2025 | By Dineshwori | 261
US FDA Appoints Richard Pazdur as Director of CDER
Pazdur is a 26-year veteran of the FDA and the Founding Director of its Oncology Center of Excellence (CoE). A regulatory innovator, he developed an integrated approach for cross-centre coordination of oncology product review to expedite the development of novel cancer therapies.
Center For Drug Evaluation And Research (CDER) | 13/11/2025 | By Dineshwori | 135
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy